Policies & Positions

  • Medical Device Tax

    Under the 2.3 percent medical device excise tax, device manufacturers are required to pay the IRS an estimated average of $194 million per month in medical device tax payments (with a payment of approximately $97 million due semimonthly). In a competitive global industry, this tax threatens an industry that contributes to more than 300,000 jobs nationwide, generates approximately $25 billion in payroll, pays out salaries that are 40 percent higher than the national average ($58,000 vs. $42,000) and invests nearly $10 billion in research and development annually.

    Learn More
  • Reimbursement & Patient Access

    Medicare reimbursement to physicians for advanced medical imaging (CT, MR, PET and nuclear medicine) has declined significantly in recent years.

    Learn More
  • FDA Regulation

    MITA believes that transparency is key to a smooth and efficient regulatory process and that lack of regulatory predictability is a significant barrier to product innovation.

    Learn More
  • MITA Smart Initiative

    The MITA Smart Dose standard offers healthcare providers a reference to identify important tools to optimize and manage radiation dose delivery when using computed tomography (CT) equipment. MITA Smart Dose, or XR 29 Standard Attributes on Computed Tomography (CT) Equipment Related to Dose Optimization and Management, bundles four key dose optimization features to ensure that compliant CT equipment produces high-quality diagnostic images while supporting patient safety.

    Learn More
  • Radiation Dose & Safety

    As part of its ongoing commitment to ensuring safe, appropriate and effective medical imaging and radiation therapy, MITA supports seven key principles to reduce exposure to unnecessary radiation and is taking the lead in unprecedented patient protection initiatives.

    Learn More
  • Health Information Technology

    Central to medicine is the ability of health information technology to connect health care systems together using appropriate standards so that data can flow and be understood between different systems.

    Learn More
  • Comparative Effectiveness

    MITA supports utilizing diagnostically appropriate comparative effectiveness research to improve the quality of health care. However, in order for the goals of comparative effectiveness to work for patients, it must emphasize clinical effectiveness rather than only cost effectiveness.

    Learn More
  • Sunshine Reporting of Payments to Physicians

    MITA resources and links to external resources on the Patient Protection and Affordable Care Act’s Sunshine Provision.

    Learn More
  • Security and Privacy

    Approved tutorials and recommendations from the Joint Security and Privacy Committee on security and privacy issues and best practices.

    Learn More
  • MITA Comment Letters & Policy Papers

    Learn More

  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More

  • The State of Medical Imaging

    New MITA Infographic highlights the current threats to medical imaging, as well as patient-centered policy proposals. Learn More

  • Navidea

    Why I Joined MITA – Navidea Biopharmaceuticals

    Hear from Thomas Tulip, Executive Vice President and Chief Business Officer of Navidea Biopharmaceuticals, on why his organization joined MITA.

    Learn More